News BriefsTechnology

Thermo Fisher To Buy Covid-19 Test Maker Mesa Biotech For $450 Million

Innovative science firm Thermo Fisher Scientific recently announced that they are dishing out $450 million on cash to buy Mesa Biotech, the company that launched one of the first Covid-19 rapid tests. Mesa Biotech is privately held and credited with helping to increase the availability of Covid-19 tests.

Mesa Biotech provides rapid testing for infectious diseases such as Influenza A and B, respiratory syncytial virus, Strep A, and SARS-CoV-2. Thermo Fisher plans to offer another $100 million contingent on the completion of certain milestones after the transaction is done.

Read More: Thermo Fisher To Buy Covid-19 Test Maker Mesa Biotech For $450 Million

OODA Analyst

OODA Analyst

OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.